Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016
Jarlier, V., Diaz Högberg, L., Heuer, O.E., Campos, J., Eckmanns, T., Giske, C.G., Grundmann, H., Johnson, A.P., Kahlmeter, G., Monen, J., Pantosti, A., Rossolini, G.M., van de Sande-Bruinsma, N., Vatopoulos, A., Żabicka, D., Žemličková, H., Monnet, D.L., Simonsen, G.S., Ears-Net Participants
ECDC country visit to Norway to discuss antimicrobial resistance issues
An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.
Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - ECDC PPS validation protocol version 3.1.2.
This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.
Surveillance systems overview for 2017
This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2017.
- Chikungunya virus disease
- Chlamydia infection
- Crimean-Congo haemorrhagic fever
- Ebola haemorrhagic fever
- Hantavirus infection
- Healthcare-associated infections
- Hepatitis A
- Hepatitis B
- Hepatitis C
- HIV infection
- Invasive Haemophilus influenzae disease
- Lassa fever
- Marburg haemorrhagic fever
- Meningococcal disease
- Pneumococcal disease
- Q fever
- Rift Valley fever
- Severe acute respiratory syndrome (SARS)
- Surgical site infections
- Verotoxigenic Escherichia coli infection
- West Nile virus infection
- Yellow fever
Incidence and attributable mortality of healthcare-associated infections in intensive care units in Europe, 2008-2012
This report provides a comprehensive update of the epidemiology of pneumonia, bloodstream infections and urinary tract infections European ICUs as well as important reference data for European ICUs performing surveillance of ICU-acquired infections.
Course on “Control of multidrug-resistant micro-organisms (MDROs) in health care settings”
The main objective of the course was to strengthen capacity in EU Member States for control of healthcare-associated infections due to multidrug-resistant organisms (MDROs) in acute health care settings and to promote the broadest possible implementation of appropriate methods.
Survey on antimicrobial resistance in intensive care units currently open
Antibiotic resistance is a threat to public health. It compromises the treatment of infected patients, in particular that of the most severely ill patients. Increasingly, intensive care physicians in Europe are confronted with infections caused by bacteria for which limited or no adequate treatment options are available.
Surveillance of surgical site infections and prevention indicators in European hospitals - HAISSI protocol
This protocol is to ensure standardisation of definitions, data collection and reporting procedures for hospitals participating in the national/regional surveillance of surgical site infections across Europe.
Surveillance of healthcare-associated infections and prevention indicators in European intensive care units: HAI-Net ICU protocol, version 2.2
This protocol is to ensure standardisation of definitions, data collection and reporting procedures for hospitals participating in the national/regional surveillance of healthcare-associated infections in intensive care units across Europe.